130 related articles for article (PubMed ID: 37199468)
21. Host-directed editing of the SARS-CoV-2 genome.
Mourier T; Sadykov M; Carr MJ; Gonzalez G; Hall WW; Pain A
Biochem Biophys Res Commun; 2021 Jan; 538():35-39. PubMed ID: 33234239
[TBL] [Abstract][Full Text] [Related]
22. Mutational Asymmetries in the SARS-CoV-2 Genome May Lead to Increased Hydrophobicity of Virus Proteins.
Matyášek R; Řehůřková K; Berta Marošiová K; Kovařík A
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34072181
[TBL] [Abstract][Full Text] [Related]
23. Mutations on COVID-19 diagnostic targets.
Wang R; Hozumi Y; Yin C; Wei GW
Genomics; 2020 Nov; 112(6):5204-5213. PubMed ID: 32966857
[TBL] [Abstract][Full Text] [Related]
24. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
[TBL] [Abstract][Full Text] [Related]
25. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
26. The Roles of APOBEC-mediated RNA Editing in SARS-CoV-2 Mutations, Replication and Fitness.
Kim K; Calabrese P; Wang S; Qin C; Rao Y; Feng P; Chen XS
Res Sq; 2022 Apr; ():. PubMed ID: 35441170
[TBL] [Abstract][Full Text] [Related]
27. Detection of A-to-I RNA Editing in SARS-COV-2.
Picardi E; Mansi L; Pesole G
Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052382
[TBL] [Abstract][Full Text] [Related]
28. Cellular senescence as a source of SARS-CoV-2 quasispecies.
Karakasiliotis I; Lagopati N; Evangelou K; Gorgoulis VG
FEBS J; 2023 Mar; 290(5):1384-1392. PubMed ID: 34653312
[TBL] [Abstract][Full Text] [Related]
29. The Mutational Landscape of SARS-CoV-2.
Saldivar-Espinoza B; Garcia-Segura P; Novau-Ferré N; Macip G; Martínez R; Puigbò P; Cereto-Massagué A; Pujadas G; Garcia-Vallve S
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240420
[TBL] [Abstract][Full Text] [Related]
30. Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples.
Aroldi A; Angaroni F; D'Aliberti D; Spinelli S; Crespiatico I; Crippa V; Piazza R; Graudenzi A; Ramazzotti D
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680048
[TBL] [Abstract][Full Text] [Related]
31. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.
Yan B; Chakravorty S; Mirabelli C; Wang L; Trujillo-Ochoa JL; Chauss D; Kumar D; Lionakis MS; Olson MR; Wobus CE; Afzali B; Kazemian M
J Virol; 2021 Jul; 95(15):e0029421. PubMed ID: 33980601
[TBL] [Abstract][Full Text] [Related]
32. The efficacy and safety of SARS-CoV-2 vaccines mRNA1273 and BNT162b2 might be complicated by rampant C-to-U RNA editing.
Bian Z; Wu Z; Liu N; Jiang X
J Appl Genet; 2023 May; 64(2):361-365. PubMed ID: 36943642
[TBL] [Abstract][Full Text] [Related]
33. Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic.
Klimczak LJ; Randall TA; Saini N; Li JL; Gordenin DA
PLoS One; 2020; 15(10):e0237689. PubMed ID: 33006981
[TBL] [Abstract][Full Text] [Related]
34. Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome.
Nakata Y; Ode H; Kubota M; Kasahara T; Matsuoka K; Sugimoto A; Imahashi M; Yokomaku Y; Iwatani Y
Nucleic Acids Res; 2023 Jan; 51(2):783-795. PubMed ID: 36610792
[TBL] [Abstract][Full Text] [Related]
35. No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2.
van Dorp L; Richard D; Tan CCS; Shaw LP; Acman M; Balloux F
Nat Commun; 2020 Nov; 11(1):5986. PubMed ID: 33239633
[TBL] [Abstract][Full Text] [Related]
36. Ongoing Positive Selection Drives the Evolution of SARS-CoV-2 Genomes.
Hou Y; Zhao S; Liu Q; Zhang X; Sha T; Su Y; Zhao W; Bao Y; Xue Y; Chen H
Genomics Proteomics Bioinformatics; 2022 Dec; 20(6):1214-1223. PubMed ID: 35760317
[TBL] [Abstract][Full Text] [Related]
37. Mutations in the genome of severe acute respiratory syndrome coronavirus 2: implications for COVID-19 severity and progression.
Al-Qahtani AA
J Int Med Res; 2022 Mar; 50(3):3000605221086433. PubMed ID: 35352580
[TBL] [Abstract][Full Text] [Related]
38. Viral transmission and evolution dynamics of SARS-CoV-2 in shipboard quarantine.
Yeh TY; Contreras GP
Bull World Health Organ; 2021 Jul; 99(7):486-495. PubMed ID: 34248221
[TBL] [Abstract][Full Text] [Related]
39. Genome-Wide Analysis of Codon Usage Patterns of SARS-CoV-2 Virus Reveals Global Heterogeneity of COVID-19.
Khattak S; Rauf MA; Zaman Q; Ali Y; Fatima S; Muhammad P; Li T; Khan HA; Khan AA; Ngowi EE; Wu DD; Ji XY
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207362
[TBL] [Abstract][Full Text] [Related]
40. In Silico Study of Mutational Stability of SARS-CoV-2 Proteins.
Chaudhuri D; Majumder S; Datta J; Giri K
Protein J; 2021 Jun; 40(3):328-340. PubMed ID: 33890205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
